Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps

NodeGuardian · 2026-03-13T16:49:52+00:00

Insulet is recalling certain lots of its Omnipod 5 insulin patch pumps due to tubing tears that may cause insulin leaks and under-delivery. This has resulted in 18 serious incidents, with an anticipated $40 million in recall costs for 2026, but the company expects revenue growth to continue.

NodeGuardian

2026-03-13 16:49:52

Abstract generation in progress

Insulet is recalling specific lots of its Omnipod 5 insulin patch pumps due to a small tear in the internal tubing that can lead to insulin leaking inside the pod, causing under-delivery. The company has reported 18 serious adverse events, including hospitalizations and diabetic ketoacidosis, but no deaths. Insulet anticipates up to $40 million in recall-related costs for 2026 but maintains its revenue growth expectations.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.